Skip to content Skip to footer

Latest News

Elon Musk’s xAI’s Record-Breaking Star-Studded Funding – $TSLA $NVDA $AMD $SPY
Based on reports from Business Insider, Elon Musk's artificial intelligence company xAI has secured a staggering $6 billion in Series…
Eupraxia Pharma’s DiffuSphere Technology Has Shown Promising Results In Pain, Infectious Diseases, Eye Diseases And Cancers
Eupraxia Pharma's (NASDAQ: EPRX) DiffuSphere technology has shown promising results in targeted drug delivery for cancer treatment. The company recently…
Insulin Pump Market Experiencing Innovation Surge – Beta Bionics Upsized IPO – Modular Medical FDA Clearance – $BBNX $MODD
The insulin pump market is experiencing a surge of innovation, with Beta Bionics targeting a $695 million valuation in its…
Beta Bionics Upsizes IPO On Thursday As Insulin Pump Market Sees Innovation Surge – $BBNX $MODD
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its…
Serina Therapeutics (NYSE: SER) Secures JuvVentures (UK) Limited Equity Premium Financing To Advance Parkinson’s Disease Trials
Serina Therapeutics (NYSE: SER, $4.91) has secured the second $5 million tranche of a $10 million equity financing deal, strengthening…
Your Guide To Staying Informed In The Markets

Subscribe For Free Email Updates Access To Exclusive Research

Vista Partners — © 2025 — Vista Partners LLC (“Vista”) is a Registered Investment Advisor in the State of California. Vista is not licensed as a broker, broker-dealer, market maker, investment banker, or underwriter in any jurisdiction. By viewing this website and all of its pages, you agree to our terms. Read the full disclaimer here